Alliance nationale pour les sciences de la vie et de la santé

Recent papers from Alliance nationale pour les sciences de la vie et de la santé

1. Coated or chewable Aspirin and a hybrid air pollution mitigation strategy in patients with atherosclerotic disease: Rationale and Design of the COATED-AIR Randomized Trial.2026
2. Prospective Systematic Screening for Transthyretin Amyloid Cardiomyopathy in Cardiology Inpatients With Left Ventricular Hypertrophy: the IMPACT StudyEuropean Heart Journal - Cardiovascular Imaging · 2026
3. Antiplatelet and Anticoagulant Therapy in the 2025 ACC/AHA Guideline for Acute Coronary SyndromesJournal of the American College of Cardiology · 2025
4. Adrenomedullin system dysregulation predicts cardiogenic shock and mortality in acute coronary syndromesEuropean Heart Journal · 2026
5. Milvexian with Antiplatelet Therapy after Acute Coronary Syndrome EventNew England Journal of Medicine · 2026
6. Perspectives on the Future of Clinical Trials at CirculationCirculation · 2026
7. Sex Differences in Trajectories of LDL Cholesterol Control in Chronic Coronary SyndromesEuropean Journal of Preventive Cardiology · 2026
8. Unsupervised clustering identifies distinct phenotypes in acute myocardial infarction: insights from the FAST-MI 2015 registryFrontiers in Artificial Intelligence · 2026
9. Biomarker-Based Risk Model to Predict Cardiovascular Mortality in Patients With Stable Coronary DiseaseJournal of the American College of Cardiology · 2017
10. Lipoprotein(a), smoking, and diabetes are additive but not interactive risk factors for major adverse cardiovascular events after acute coronary syndromeAmerican Journal of Preventive Cardiology · 2026
11. Restrictive vs Liberal Transfusion Strategy After Myocardial InfarctionJAMA Network Open · 2026
12. Design of VICTORION-2 Prevent: a randomized double-blind, placebo-controlled trial, assessing the impact of inclisiran on major adverse cardiovascular events in patients with established cardiovascular diseaseAmerican Heart Journal · 2026
13. Rifampicin for the treatment of a cardiogenic shock related to mavacamten toxicity: the worse and the best of drug interactions from a case reportEuropean Heart Journal - Case Reports · 2026
14. Anticoagulation and Antiplatelet Therapy for Atrial Fibrillation and Stable Coronary DiseaseJournal of the American College of Cardiology · 2025
15. Interleukin-6 and C-reactive protein prognostic value following acute coronary syndromeEuropean Heart Journal · 2026
16. Prediction of incident heart failure in established atherosclerotic cardiovascular disease: the SMART2-HF model.2026
17. Low-Dose Rivaroxaban to Prevent Left Ventricular Thrombosis After Anterior Myocardial InfarctionJAMA Cardiology · 2026
18. A Comprehensive Set of Per-Protocol Analyses of the Myocardial Ischemia and Transfusion (MINT) TrialAmerican Heart Journal · 2026
19. Effects of Icosapent Ethyl on Risk and Duration of Hospitalizations and Death in REDUCE-ITEuropean Journal of Preventive Cardiology · 2026
20. From myocarditis to pericarditis: A new conceptual framework of inflammatory myopericardial syndrome in the European Society of Cardiology 2025 guidelinesArchives of cardiovascular diseases · 2026